Compare Eli Lilly And Co (LLY) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Koninklijke Philips NV — how do they compare? Eli Lilly And Co trades at $1,173.2 (market cap $1.02T), while Koninklijke Philips NV trades at $26.77 (market cap $26.19B). The key difference: Eli Lilly And Co is far larger — about 38.9× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.79%). Which is the better fit depends on your goals.
| LLY | PHG | |
|---|---|---|
Market Cap | $1.02T | $26.19B |
Sector | Health | Health |
52-Week High | $1.24K | $32.91 |
52-Week Low | $625.65 | $24.54 |
Enterprise Value | $1.06T | $32.46B |
Dividend Yield | 0.6% | 3.79% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
